These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 30420481)

  • 1. High-Dosage Cefazolin Achieves Sufficient Cerebrospinal Diffusion To Treat an External Ventricular Drainage-Related
    Grégoire M; Gaborit B; Deschanvres C; Lecomte R; Deslandes G; Dailly É; Ambrosi X; Bellouard R; Asseray N; Lakhal K; Boutoille D
    Antimicrob Agents Chemother; 2019 Feb; 63(2):. PubMed ID: 30420481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Continued in vitro cefazolin susceptibility in methicillin-susceptible Staphylococcus aureus.
    Gern BH; Greninger AL; Weissman SJ; Stapp JR; Tao Y; Qin X
    Ann Clin Microbiol Antimicrob; 2018 Feb; 17(1):5. PubMed ID: 29463249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of a Cefazolin Inoculum Effect Associated with
    Wang SK; Gilchrist A; Loukitcheva A; Plotkin BJ; Sigar IM; Gross AE; O'Donnell JN; Pettit N; Buros A; O'Driscoll T; Rhodes NJ; Bethel C; Segreti J; Charnot-Katsikas A; Singh K; Scheetz MH
    Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29891607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Should we reconsider cefazolin for treating staphylococcal meningitis? A retrospective analysis of cefazolin and cloxacillin cerebrospinal fluid levels in patients treated for staphylococcal meningitis.
    Le Turnier P; Gregoire M; Deslandes G; Lakhal K; Deschanvres C; Lecomte R; Talarmin JP; Dubée V; Bellouard R; Boutoille D; Leroy AG; Gaborit BJ;
    Clin Microbiol Infect; 2020 Oct; 26(10):1415.e1-1415.e4. PubMed ID: 32437956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical implications of cefazolin inoculum effect and β-lactamase type on methicillin-susceptible Staphylococcus aureus bacteremia.
    Lee S; Kwon KT; Kim HI; Chang HH; Lee JM; Choe PG; Park WB; Kim NJ; Oh MD; Song DY; Kim SW
    Microb Drug Resist; 2014 Dec; 20(6):568-74. PubMed ID: 25000230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative time-kill study of doxycycline, tigecycline, cefazolin and vancomycin against several clones of Staphylococcus aureus.
    Herrera M; Mobilia L; Posse G; Limansky A; Ballerini V; Bantar C
    Curr Clin Pharmacol; 2013 Nov; 8(4):332-9. PubMed ID: 23590512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Population pharmacokinetics of cefazolin in critically ill children infected with methicillin-sensitive Staphylococcus aureus.
    Salvador E; Oualha M; Bille E; Beranger A; Moulin F; Benaboud S; Boujaafar S; Gana I; Urien S; Zheng Y; Toubiana J; Briand C; Bustarret O; Geslain G; Renolleau S; Treluyer JM; Hirt D
    Clin Microbiol Infect; 2021 Mar; 27(3):413-419. PubMed ID: 32360445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Staphylococcus aureus Central Nervous System Infections in Children.
    Vallejo JG; Cain AN; Mason EO; Kaplan SL; Hultén KG
    Pediatr Infect Dis J; 2017 Oct; 36(10):947-951. PubMed ID: 28399057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics of cefazolin inoculum effect-positive methicillin-susceptible staphylococcus aureus infection in a multicentre bacteraemia cohort.
    Song KH; Jung SI; Lee S; Park S; Kiem SM; Lee SH; Kwak YG; Kim YK; Jang HC; Kim YS; Kim HI; Kim CJ; Park KH; Kim NJ; Oh MD; Kim HB;
    Eur J Clin Microbiol Infect Dis; 2017 Feb; 36(2):285-294. PubMed ID: 27714592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retrospective Analysis of Adverse Drug Events Between Nafcillin Versus Cefazolin for Treatment of Methicillin-Susceptible
    Chan L; Chan-Tompkins NH; Como J; Guarascio AJ
    Ann Pharmacother; 2020 Jul; 54(7):662-668. PubMed ID: 31888347
    [No Abstract]   [Full Text] [Related]  

  • 11. Implementation of a cefazolin-based stewardship pathway for methicillin-susceptible Staphylococcus aureus bloodstream infections paired with infectious diseases consultation.
    Lee BJ; Rao SN; Wang SK; Lee JY; Lakada IY; Gilbert EM; Barr VO; Postelnick MJ; Sutton SH; Zembower TR; Bolon M; Scheetz MH; Rhodes NJ
    Int J Antimicrob Agents; 2017 May; 49(5):650-654. PubMed ID: 28279787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of blaZ gene types and the inoculum effect with cefazolin among bloodstream isolates of methicillin-susceptible Staphylococcus aureus.
    Livorsi DJ; Crispell E; Satola SW; Burd EM; Jerris R; Wang YF; Farley MM
    Antimicrob Agents Chemother; 2012 Aug; 56(8):4474-7. PubMed ID: 22585225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inoculum effect of high concentrations of methicillin-susceptible Staphylococcus aureus on the efficacy of cefazolin and other beta-lactams.
    Saeki M; Shinagawa M; Yakuwa Y; Nirasawa S; Sato Y; Yanagihara N; Takahashi S
    J Infect Chemother; 2018 Mar; 24(3):212-215. PubMed ID: 29198902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An infant with an MRSA ventriculo-gallbladder shunt infection.
    Weiner GM; Bui CJ; Steele RW
    Clin Pediatr (Phila); 2011 Mar; 50(3):269-71. PubMed ID: 21307082
    [No Abstract]   [Full Text] [Related]  

  • 15. β-Lactam Therapy for Methicillin-Susceptible Staphylococcus aureus Bacteremia: A Comparative Review of Cefazolin versus Antistaphylococcal Penicillins.
    Li J; Echevarria KL; Traugott KA
    Pharmacotherapy; 2017 Mar; 37(3):346-360. PubMed ID: 28035690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nafcillin versus cefazolin for the treatment of methicillin-susceptible Staphylococcus aureus bacteremia.
    Monogue ML; Ortwine JK; Wei W; Eljaaly K; Bhavan KP
    J Infect Public Health; 2018; 11(5):727-731. PubMed ID: 29526442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inoculum effect with cefazolin among clinical isolates of methicillin-susceptible Staphylococcus aureus: frequency and possible cause of cefazolin treatment failure.
    Nannini EC; Stryjewski ME; Singh KV; Bourgogne A; Rude TH; Corey GR; Fowler VG; Murray BE
    Antimicrob Agents Chemother; 2009 Aug; 53(8):3437-41. PubMed ID: 19487449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A large retrospective cohort study of cefazolin compared with flucloxacillin for methicillin-susceptible Staphylococcus aureus bacteraemia.
    Davis JS; Turnidge J; Tong S
    Int J Antimicrob Agents; 2018 Aug; 52(2):297-300. PubMed ID: 29499317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular graft infection by Staphylococcus aureus: efficacy of cefazolin, teicoplanin and vancomycin prophylaxis protocols in a rat model.
    Atahan E; Gul M; Ergun Y; Eroglu E
    Eur J Vasc Endovasc Surg; 2007 Aug; 34(2):182-7. PubMed ID: 17481929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methicillin-Susceptible Staphylococcus Aureus Bacteremia: Cefazolin in Prime But Nafcillin Not Ready for an Exit.
    Sarria JC
    Am J Med Sci; 2020 Jul; 360(1):3-4. PubMed ID: 32439151
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.